In studies of mice with intrastriatally implanted glioma cells, B1R selective antagonist-treated mice and B1R knockout mice showed a remarkable increase in tumour invasiveness, as indicated by tumour size or mitotic index [11]. This evidence concerns the gene BDKRB1 and central nervous system cancer.